Literature DB >> 8796157

The effect of prophylactic acetazolamide in patients undergoing extensive retinal detachment repair.

B Edmunds1, C R Canning.   

Abstract

Encirclement of the eye as part of a retinal detachment repair is known to raise the post-operative intraocular pressure. We studied the effect of anticipating this pressure rise by giving perioperative acetazolamide to patients having vitrectomy and encirclement procedures. Two groups (9 with acetazolamide and 14 without) were matched for biographic variables, type of detachment and operation variables. The group given acetazolamide had lower day 1 post-operative intraocular pressures (mean 22.11 mmHg vs 36.36 mmHg, p = 0.002) and were able to go home sooner (mean 1.56 days vs 3.29 days, p = 0.001). No adverse effects of short-term acetazolamide use were noted in this study. We conclude that patients having extensive scleral buckling procedures should all receive prophylactic acetazolamide unless it is specifically contraindicated.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8796157     DOI: 10.1038/eye.1996.68

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  3 in total

1.  The use of topical aqueous suppressants in the prevention of postoperative intraocular pressure elevation following pars plana vitrectomy with long-acting gas tamponade.

Authors:  R A Mittra; J S Pollack; S Dev; D P Han; W F Mieler; T B Connor
Journal:  Trans Am Ophthalmol Soc       Date:  1998

2.  Combined scleral buckling and phacoemulsification.

Authors:  Pukhraj Rishi; Tarun Sharma; Ekta Rishi; Soumendra P Chaudhary
Journal:  Oman J Ophthalmol       Date:  2009-01

3.  The Combination of Ketorolac with Local Anesthesia for Pain Control in Day Care Retinal Detachment Surgery: A Randomized Controlled Trial.

Authors:  Xiaohong Chen; Bingqian Liu; Xiaoling Liang; Jiaqing Li; Tao Li; Yonghao Li; Xiling Yu; Cancan Lyu; Xiujuan Zhao; Silvia Tanumiharjo; Chenjin Jin; Lin Lu
Journal:  J Ophthalmol       Date:  2017-07-09       Impact factor: 1.909

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.